51 related articles for article (PubMed ID: 29027212)
21. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose.
Elford P; Bouchard J; Jaillet L; Pearson N; Rogue A; Sabadie C; Forster R
J Pharmacol Toxicol Methods; 2013; 68(3):374-83. PubMed ID: 23624021
[TBL] [Abstract][Full Text] [Related]
22. Iron sucrose: assessing the similarity between the originator drug and its intended copies.
Di Francesco T; Philipp E; Borchard G
Ann N Y Acad Sci; 2017 Nov; 1407(1):63-74. PubMed ID: 29168243
[TBL] [Abstract][Full Text] [Related]
23. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
[No Abstract] [Full Text] [Related]
24. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Bhavi SB; Jaju PB
BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
[TBL] [Abstract][Full Text] [Related]
25. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
Pai AB
Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
[TBL] [Abstract][Full Text] [Related]
26. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
27. Targeting Iron Deficiency Anemia in Heart Failure.
Saraon T; Katz SD
Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
[TBL] [Abstract][Full Text] [Related]
28. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Nash CM; Allen VM
J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
[TBL] [Abstract][Full Text] [Related]
29. Iron Treatment Strategies in Nondialysis CKD.
Macdougall IC
Semin Nephrol; 2016 Mar; 36(2):99-104. PubMed ID: 27236130
[TBL] [Abstract][Full Text] [Related]
30. The role of intravenous iron in anemia management and transfusion avoidance.
Auerbach M; Goodnough LT; Picard D; Maniatis A
Transfusion; 2008 May; 48(5):988-1000. PubMed ID: 18346021
[No Abstract] [Full Text] [Related]
31. Update on intravenous iron choices.
Larson DS; Coyne DW
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):186-91. PubMed ID: 24401789
[TBL] [Abstract][Full Text] [Related]
32. Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.
Michael B; Fishbane S; Coyne DW; Agarwal R; Warnock DG
Nat Clin Pract Nephrol; 2006 Feb; 2(2):92-100. PubMed ID: 16932400
[TBL] [Abstract][Full Text] [Related]
33. Intravenous iron products.
Johnson CA; Mason NA; Bailie GR
ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
[TBL] [Abstract][Full Text] [Related]
34. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.
Macdougall IC; Comin-Colet J; Breymann C; Spahn DR; Koutroubakis IE
Adv Ther; 2020 May; 37(5):1960-2002. PubMed ID: 32297281
[TBL] [Abstract][Full Text] [Related]
35. Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC; Geisser P
Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
[TBL] [Abstract][Full Text] [Related]
36. Is intravenous iron sucrose the treatment of choice for pregnant anemic women?
Devasenapathy N; Neogi SB; Zodpey S
J Obstet Gynaecol Res; 2013 Mar; 39(3):619-26. PubMed ID: 23167561
[TBL] [Abstract][Full Text] [Related]
37. Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
Beguin Y; Jaspers A
Expert Opin Pharmacother; 2014 Oct; 15(14):2087-103. PubMed ID: 25186219
[TBL] [Abstract][Full Text] [Related]
38. [Importance of the different i.v. iron generations for everyday medical practice].
Biggar P; Hahn KM
MMW Fortschr Med; 2013 Mar; 155 Suppl 1():18-24. PubMed ID: 23678667
[TBL] [Abstract][Full Text] [Related]
39. Parenteral iron use in the management of anemia in end-stage renal disease patients.
Bailie GR; Johnson CA; Mason NA
Am J Kidney Dis; 2000 Jan; 35(1):1-12. PubMed ID: 10620537
[TBL] [Abstract][Full Text] [Related]
40. Iron Oxide Nanoparticle Formulations for Supplementation.
Pai AB
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
